Tuesday, May 13, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: KeifeRx LLC’s KFRX01

Novartis

Novartis’s drug Tasigna faces sales decline 

HTP Desk - 0
Novartis drug Tasigna (nilotinib) is set to lose its exclusive status in the US in January 2024. A pivotal treatment for chronic myeloid leukemia (CML),...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!